Literature DB >> 10566780

Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.

P J Hauer1, N E Clough.   

Abstract

The quality control testing of clostridial veterinary vaccines currently requires large numbers of animals. Alternative in vitro test methods are being investigated by researchers in industry and by regulatory authorities in many countries. Monoclonal antibodies that neutralize Clostridium perfringens alpha toxin, C. perfringens beta toxin, C. perfringens epsilon toxin, and C. sordellii lethal toxin as well as a monoclonal antibody directed against C. chauvoei flagellar antigen have been developed by the Center for Veterinary Biologics-Laboratory for use in antigen quantification assays. A proposal to create an international standard collection of clostridial-specific monoclonal antibodies is made.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566780

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  10 in total

1.  Epsilon-toxin plasmids of Clostridium perfringens type D are conjugative.

Authors:  Meredith L Hughes; Rachael Poon; Vicki Adams; Sameera Sayeed; Juliann Saputo; Francisco A Uzal; Bruce A McClane; Julian I Rood
Journal:  J Bacteriol       Date:  2007-08-24       Impact factor: 3.490

2.  A tripartite cocktail of chimeric monoclonal antibodies passively protects mice against ricin, staphylococcal enterotoxin B and Clostridium perfringens epsilon toxin.

Authors:  Erin K Sully; Kevin Whaley; Natasha Bohorova; Ognian Bohorov; Charles Goodman; Do Kim; Michael Pauly; Jesus Velasco; Frederick W Holtsberg; Eric Stavale; M Javad Aman; Chandra Tangudu; Francisco A Uzal; Nicholas J Mantis; Larry Zeitlin
Journal:  Toxicon       Date:  2014-09-28       Impact factor: 3.033

3.  Prevention and treatment of Clostridium perfringens epsilon toxin intoxication in mice with a neutralizing monoclonal antibody (c4D7) produced in Nicotiana benthamiana.

Authors:  J P Garcia; J Beingesser; O Bohorov; N Bohorova; C Goodman; D Kim; M Pauly; J Velasco; K Whaley; L Zeitlin; C J Roy; F A Uzal
Journal:  Toxicon       Date:  2014-06-17       Impact factor: 3.033

4.  Identification of amino acids important for binding of Clostridium perfringens epsilon toxin to host cells and to HAVCR1.

Authors:  Susan E Ivie; Mark S McClain
Journal:  Biochemistry       Date:  2012-09-12       Impact factor: 3.162

5.  Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin.

Authors:  Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

6.  Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen.

Authors:  Michelle Lewis; Charles David Weaver; Mark S McClain
Journal:  Toxins (Basel)       Date:  2010-07-01       Impact factor: 5.075

7.  Dominant-negative inhibitors of the Clostridium perfringens epsilon-toxin.

Authors:  Teal M Pelish; Mark S McClain
Journal:  J Biol Chem       Date:  2009-08-31       Impact factor: 5.157

8.  Lethal toxin is a critical determinant of rapid mortality in rodent models of Clostridium sordellii endometritis.

Authors:  Yibai Hao; Tennille Senn; Judy S Opp; Vincent B Young; Teri Thiele; Geetha Srinivas; Steven K Huang; David M Aronoff
Journal:  Anaerobe       Date:  2009-06-13       Impact factor: 3.331

9.  Gene-trap mutagenesis identifies mammalian genes contributing to intoxication by Clostridium perfringens ε-toxin.

Authors:  Susan E Ivie; Christine M Fennessey; Jinsong Sheng; Donald H Rubin; Mark S McClain
Journal:  PLoS One       Date:  2011-03-11       Impact factor: 3.240

10.  Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination.

Authors:  Jennifer R Linden; Yinghua Ma; Baohua Zhao; Jason Michael Harris; Kareem Rashid Rumah; Nicole Schaeren-Wiemers; Timothy Vartanian
Journal:  MBio       Date:  2015-06-16       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.